Developer docs
API playgroundTry for free, no card

Search company profiles

TrakCel

Full company profile

uuid0004kqe

Namestring
TrakCel
Legal namestring
TrakCel
Websiteurl
trakcel.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

TrakCel is a UK-headquartered (Cardiff) software company founded in 2012 that builds OCELLOS, a second-generation advanced therapy orchestration platform purpose-built for cell and gene therapy (CGT) manufacturers. OCELLOS is delivered natively on Salesforce.com, extended via a MuleSoft-powered Integration Hub, and orchestrates the end-to-end patient-to-product journey — including Chain of Identity (COI) and Chain of Custody (COC) tracking, patient enrollment, scheduling, manufacturing coordination, courier booking, labelling, and administration — using a "clicks not code" modular configuration methodology. As of Q3 2025, OCELLOS is live at 350+ sites across 18 countries with 3,000+ trained users, 20+ therapies (including 5 commercial), 1,000+ enrolled patients, and is available in six languages.

TrakCel monetizes primarily through multi-year SaaS subscriptions across three OCELLOS tiers (Blueprint, Configured, Self-Config), supplemented by an OCELLOS Pay-As-You-Go offering for emerging biotechs (launched October 2025), a SAP CGTO-integrated bundle, and adjacent modules including the CGT Gateway (treatment-center unified access layer), the Therapy Command Center, and the TrakCel Connected Chain. Revenue is augmented by TrakCel Consulting Services and SI & Digital Transformation Services for configuration, validation, and commercial-launch support. Go-to-market combines direct enterprise field sales, a CRO/CDMO/logistics channel partner ecosystem, Salesforce AppExchange marketplace listing, and event-driven demand generation across Advanced Therapies Congress, CAR-TCR, and Cell & Gene Therapy World Asia.

The company is privately held and founder-controlled (Ravi Nalliah, CEO; Dr. Matthew Lakelin and Dr. Akshay Peer as co-founders). Strategic shareholders include Cencora (formerly AmerisourceBergen) and Labcorp from a 2021 funding event, alongside earlier backing from Telegraph Hill Partners and Catalyst Growth Partners in 2016. TrakCel holds ISO/IEC 27001 certification (achieved 2026), is named to The Sunday Times 100 Tech (2025), and was recognized by The Scientist as a Top 10 Innovation (2022). The company operates offices in Cardiff (UK) and San Francisco (US) and reports 11–50 employees.

Short descriptiontext

TrakCel provides OCELLOS, a Salesforce-based orchestration platform for cell and gene therapy manufacturers and treatment centers, enabling end-to-end chain of identity and custody tracking, scheduling, and partner integration across clinical and commercial supply chains in 18 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersCardiff, United Kingdom
HQ citystring
Cardiff
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cell therapy orchestration, gene therapy software, chain of identity tracking, therapy supply chain management, cold chain logistics
Industry1 code
PRIMARYHLAGABAD
Cell Therapy CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
NAICS code2 codes
  • Software Publishers5132
  • Custom Computer Programming Services541511
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Cell and Gene Therapy Orchestration Software
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model4 records
1OCELLOS Platform Subscription
TypeSubscription Recurring
Description

SaaS subscription model for the OCELLOS orchestration platform available in Blueprint, Configured, and Self-Config deployment options. Supports clinical trial and commercial stage therapies.

trakcel.com
2OCELLOS Pay-As-You-Go (PAYG)
TypeSubscription Recurring
Description

Rapid, affordable orchestration for emerging biotechs with pay-as-you-go pricing model for early-stage companies

trakcel.com
3Professional Services and SI
TypeProfessional Services
Description

System implementation, configuration, onboarding, and digital transformation consulting services including commercial launch support, technology architecture, patient services implementation, and quality compliance

trakcel.com
4Consulting Services
TypeProfessional Services
Description

Expert consulting services for COI strategy, data protection compliance, label design, supply chain risk assessment, and SaaS validation within pharma

trakcel.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
Pricing details4 tiers
1OCELLOS Blueprint - Off-the-shelf configuration for early stage/clinical clients
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Minimal setup costs, ready-made UI and industry-specific workflows, includes ready integrations with Bartender for labeling and leading courier providers

trakcel.com
2OCELLOS Configured - Additional configuration beyond Blueprint
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Includes additional workflows and integrations with ERP or similar systems

trakcel.com
3OCELLOS with Self-Config - Customer-administered configuration
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Customer administrators trained to create/alter workflows with product guides and training modules

trakcel.com
4OCELLOS Pay-As-You-Go (PAYG)
ModelUsage-basedBilling cadencePay-as-you-go
Notes

Rapid, affordable orchestration for emerging biotechs

trakcel.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

TrakCel develops and sells OCELLOS, a Salesforce-powered, modular orchestration platform purpose-built for cell and gene therapy manufacturers. The platform digitizes and coordinates the end-to-end advanced therapy value chain — patient enrollment, scheduling, manufacturing, cryogenic logistics, and final product administration — while enforcing Chain of Identity and Chain of Custody. TrakCel also offers SI/Digital Transformation implementation services and TrakCel Consulting Services covering COI/COC strategy, regulatory compliance, label design, and SaaS validation.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Up to 50+ hours saved per week by CROs eliminating manual coordination
+2 more records
Product overview1 text field

TrakCel offers OCELLOS, a modular, Salesforce-powered advanced therapy orchestration platform designed for cell and gene therapy manufacturers. The platform comprises multiple product tiers including OCELLOS (core platform), OCELLOS Blueprint (off-the-shelf configuration), OCELLOS Configured (tailored customization), OCELLOS with SAP CGTO Integration, OCELLOS Pay-As-You-Go (for emerging biotechs), and OCELLOS Core (for early-stage development). Supporting modules include Gateway (unified site access), CGT Gateway (HCP access), and Therapy Command Center (operations visibility). The portfolio is complemented by TrakCel Consulting Services and SI & Digital Transformation Services for implementation and optimization. OCELLOS is available on Salesforce AppExchange and supports autologous, allogeneic, and personalized cancer vaccine therapies across clinical and commercial settings.

Product and service6 records
1OCELLOS
CategoryCell and Gene Therapy Orchestration Platform
Description

Modular, Salesforce-powered advanced therapy orchestration platform for cell and gene therapy manufacturers, providing end-to-end visibility from patient enrollment through manufacturing, logistics, and final product delivery with full Chain of Identity and Chain of Custody tracking. Available on Salesforce AppExchange, operational at 350+ sites across 18 countries supporting 20+ therapies.

2OCELLOS Core
CategoryCell and Gene Therapy Orchestration Platform
Description

OCELLOS Core orchestration product designed for early-stage personalized cell therapy development, supporting both autologous and allogeneic therapies in clinical trial settings.

3OCELLOS Pay-As-You-Go
CategoryCell and Gene Therapy Orchestration Platform
Description

Rapid, affordable off-the-shelf OCELLOS orchestration with pay-as-you-go pricing for emerging biotechs, providing established best-practice workflows and faster adoption without multi-year enterprise commitments.

4OCELLOS with SAP CGTO Integration
CategoryCell and Gene Therapy Orchestration Platform
Description

Combined offering integrating OCELLOS with the SAP Cell and Gene Therapy Orchestration (CGTO) module, providing a best-in-class HCP portal backed by SAP for order intake, management, invoicing, real-time updates, exception handling, and improved data governance.

5SI & Digital Transformation Services
CategoryProfessional Services
Description

System implementation and digital transformation services supporting organizations from clinical to commercial stage, including configuration, validation, data migration, training, commercial launch support, technology architecture, patient services implementation, and quality compliance.

6TrakCel Consulting Services
CategoryConsulting Services
Description

Expert consultancy covering Chain of Identity and Chain of Custody strategy, data protection compliance, label design and compliance, supply chain risk assessment, and SaaS validation within the pharmaceutical industry.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
Strategic tierCoreTypeTechnology or Integration
Description

Full integration with Lonza's MODA-ES manufacturing execution system to ensure smooth data flow between scheduling, batch execution and clinical operations. Integration eliminates manual handoffs and provides consistent visibility across manufacturing and trial teams.

Strategic tierCoreTypeTechnology or Integration
Description

Integration with Körber's PAS-X MES platform enables automated exchange of scheduling and manufacturing data. Partnership provides visibility within manufacturing and fits into TrakCel's orchestration across the wider supply chain.

Strategic tierCoreTypeTechnology or Integration
Description

Compliant label generation through BarTender software enabling consistent, compliant labels at the click of a button. Labels populate patient-specific information into approved templates regardless of location, language or treatment.

Strategic tierCoreTypeTechnology or Integration
Description

Specialty courier integration for automated shipment bookings, collection instructions and real-time shipment updates. Partnership provides full visibility and integration within the complex CGT supply chain.

Strategic tierCoreTypeTechnology or Integration
Description

Integration with Quick Specialized Healthcare Logistics for automated courier bookings and tracking. Partnership critical for time-sensitive transport of cell therapy materials.

Strategic tierCoreTypeTechnology or Integration
Description

Integration with Marken's global network of 49 sites including cryogenic service stations and GPS tracking technology for 24/7 monitoring of cell therapy shipments.

Strategic tierCoreTypeTechnology or Integration
Description

Global specialty courier integration for cell and gene therapy logistics providing on-demand access to cell therapy companies as they move through clinical trials to scaled production.

Strategic tierCoreTypeTechnology or Integration
Description

Integration with patient hub services from Cencora for real-time patient eligibility and benefits verification, live transmission of patient schedule information to case managers, and improved speed-to-therapy.

Strategic tierCoreTypeTechnology or Integration
Description

Integration with Cardinal Health patient hub services providing patient access and reimbursement solutions as part of integrated supply chain for commercial therapies.

10Be The Match BioTherapies
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Collaboration to develop custom solutions for individual programs and patient populations. Shared goal of ensuring cell and gene therapies can be developed efficiently and delivered safely to patients.

trakcel.com
Strategic tierCoreTypeTechnology or Integration
Description

Integration platform powering TrakCel's Integration Hub for standardized API connectivity. Enables secure, validated data exchange across all internal and external partners.

12ZS
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Analytics and consulting partnership to deploy expertise helping the industry shift to proactive, predictive analyses that identify and mitigate challenges in cell therapy orchestration.

Strategic tierCoreTypeTechnology or Integration
Description

Platform foundation for OCELLOS - second-generation cellular orchestration platform built on Salesforce Health Cloud and available on Salesforce AppExchange.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight8 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Healthcare-specific extension of the Salesforce platform that underpins TrakCel's OCELLOS. Comparable as the platform-of-record and a potential competitive incumbent if Salesforce expands native orchestration capabilities within Health Cloud or AppExchange.

2Vineti
TypeDirect peer
Description

Pioneer in CGT orchestration software for cell therapy manufacturers and treatment centers, offering patient scheduling, manufacturing coordination, and chain-of-custody tracking. Closest direct competitor to OCELLOS in scope and target buyer, now operating within Autolus Therapeutics' ecosystem.

TypeEmerging player
Description

Emerging cell therapy manufacturing automation company building integrated cell therapy platforms. Relevant as a next-generation CGT manufacturing technology provider whose factory-of-the-future approach intersects with TrakCel's orchestration domain.

TypeBroad incumbent
Description

Provider of quality management, manufacturing execution, and compliance software for life sciences, including CGT manufacturers. Comparable as an incumbent offering overlapping capabilities in QMS, validation, and supply-chain documentation relevant to TrakCel's customers.

TypeBroad incumbent
Description

Laboratory information management system (LIMS) provider serving pharmaceutical and biotech customers, including cell and gene therapy developers. Comparable as an adjacent incumbent whose informatics footprint could be extended into CGT chain-of-custody and sample tracking use cases.

TypeBroad incumbent
Description

Dominant cloud software provider for the life sciences industry across CRM, clinical, regulatory, and quality. Comparable as a broader incumbent in pharma enterprise software with potential to bundle CGT orchestration into its platform, posing a competitive threat from above.

TypeEmerging player
Description

Early-stage company developing automated cell and gene therapy manufacturing platforms with integrated process control. Adjacent emerging player whose manufacturing automation roadmap could overlap with TrakCel's orchestration layer in CGT production environments.

TypeBroad incumbent
Description

Enterprise ERP vendor that has launched a dedicated Cell and Gene Therapy Orchestration (CGTO) module that TrakCel integrates with. Represents the most direct large-platform competitive threat, leveraging SAP's installed base across pharma to bundle CGT orchestration.

TypeDirect peer
Description

Germany-based independent software vendor specializing in chain-of-custody and chain-of-identity orchestration for advanced therapy medicinal products. Direct competitor to TrakCel in CGT supply-chain orchestration, with comparable focus on autologous and allogeneic therapies and treatment-center workflows.

TypeBroad incumbent
Description

Life sciences R&D, manufacturing, and quality software suite within Dassault Systèmes. Comparable as a broad incumbent whose scientific informatics and lab-to-manufacturing capabilities could be extended into CGT orchestration workflows.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment8 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration17 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

TrakCel

Cell and Gene Therapy Orchestration Softwaretrakcel.com

TrakCel provides OCELLOS, a Salesforce-based orchestration platform for cell and gene therapy manufacturers and treatment centers, enabling end-to-end chain of identity and custody tracking, scheduling, and partner integration across clinical and commercial supply chains in 18 countries.

What TrakCel does

TrakCel is a UK-headquartered (Cardiff) software company founded in 2012 that builds OCELLOS, a second-generation advanced therapy orchestration platform purpose-built for cell and gene therapy (CGT) manufacturers. OCELLOS is delivered natively on Salesforce.com, extended via a MuleSoft-powered Integration Hub, and orchestrates the end-to-end patient-to-product journey — including Chain of Identity (COI) and Chain of Custody (COC) tracking, patient enrollment, scheduling, manufacturing coordination, courier booking, labelling, and administration — using a "clicks not code" modular configuration methodology. As of Q3 2025, OCELLOS is live at 350+ sites across 18 countries with 3,000+ trained users, 20+ therapies (including 5 commercial), 1,000+ enrolled patients, and is available in six languages.

TrakCel monetizes primarily through multi-year SaaS subscriptions across three OCELLOS tiers (Blueprint, Configured, Self-Config), supplemented by an OCELLOS Pay-As-You-Go offering for emerging biotechs (launched October 2025), a SAP CGTO-integrated bundle, and adjacent modules including the CGT Gateway (treatment-center unified access layer), the Therapy Command Center, and the TrakCel Connected Chain. Revenue is augmented by TrakCel Consulting Services and SI & Digital Transformation Services for configuration, validation, and commercial-launch support. Go-to-market combines direct enterprise field sales, a CRO/CDMO/logistics channel partner ecosystem, Salesforce AppExchange marketplace listing, and event-driven demand generation across Advanced Therapies Congress, CAR-TCR, and Cell & Gene Therapy World Asia.

The company is privately held and founder-controlled (Ravi Nalliah, CEO; Dr. Matthew Lakelin and Dr. Akshay Peer as co-founders). Strategic shareholders include Cencora (formerly AmerisourceBergen) and Labcorp from a 2021 funding event, alongside earlier backing from Telegraph Hill Partners and Catalyst Growth Partners in 2016. TrakCel holds ISO/IEC 27001 certification (achieved 2026), is named to The Sunday Times 100 Tech (2025), and was recognized by The Scientist as a Top 10 Innovation (2022). The company operates offices in Cardiff (UK) and San Francisco (US) and reports 11–50 employees.

TrakCel firmographics

Firmographics
Name
TrakCel
Legal name
TrakCel
Website
https://trakcel.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
51–100 employees
Short description
TrakCel provides OCELLOS, a Salesforce-based orchestration platform for cell and gene therapy manufacturers and treatment centers, enabling end-to-end chain of identity and custody tracking, scheduling, and partner integration across clinical and commercial supply chains in 18 countries.
Ownership category
akta.pro rank

TrakCel industry classification

Industry
Product category
Cell and Gene Therapy Orchestration Software
NAICS
Software Publishers (5132), Custom Computer Programming Services (541511)
SIC
Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYHLAGABAD
Cell Therapy CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

Keywords

  • Cell therapy orchestration
  • Gene therapy software
  • Chain of identity tracking
  • Therapy supply chain management
  • Cold chain logistics

Where TrakCel is headquartered

Location

Headquarters

HQ city
Cardiff
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

TrakCel business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. OCELLOS Platform Subscription: SaaS subscription model for the OCELLOS orchestration platform available in Blueprint, Configured, and Self-Config deployment options. Supports clinical trial and commercial stage therapies.
  2. OCELLOS Pay-As-You-Go (PAYG): Rapid, affordable orchestration for emerging biotechs with pay-as-you-go pricing model for early-stage companies
  3. Professional Services and SI: System implementation, configuration, onboarding, and digital transformation consulting services including commercial launch support, technology architecture, patient services implementation, and quality compliance
  4. Consulting Services: Expert consulting services for COI strategy, data protection compliance, label design, supply chain risk assessment, and SaaS validation within pharma

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractOCELLOS Blueprint - Off-the-shelf configuration for early stage/clinical clients
SubscriptionMulti-year contractOCELLOS Configured - Additional configuration beyond Blueprint
SubscriptionMulti-year contractOCELLOS with Self-Config - Customer-administered configuration
Usage-basedPay-as-you-goOCELLOS Pay-As-You-Go (PAYG)

Go-to-market motion4 records

Distribution channels5 records

Marketing channels7 records

TrakCel product offering

Product offering

Core offering

TrakCel develops and sells OCELLOS, a Salesforce-powered, modular orchestration platform purpose-built for cell and gene therapy manufacturers. The platform digitizes and coordinates the end-to-end advanced therapy value chain — patient enrollment, scheduling, manufacturing, cryogenic logistics, and final product administration — while enforcing Chain of Identity and Chain of Custody. TrakCel also offers SI/Digital Transformation implementation services and TrakCel Consulting Services covering COI/COC strategy, regulatory compliance, label design, and SaaS validation.

Product overview

TrakCel offers OCELLOS, a modular, Salesforce-powered advanced therapy orchestration platform designed for cell and gene therapy manufacturers. The platform comprises multiple product tiers including OCELLOS (core platform), OCELLOS Blueprint (off-the-shelf configuration), OCELLOS Configured (tailored customization), OCELLOS with SAP CGTO Integration, OCELLOS Pay-As-You-Go (for emerging biotechs), and OCELLOS Core (for early-stage development). Supporting modules include Gateway (unified site access), CGT Gateway (HCP access), and Therapy Command Center (operations visibility). The portfolio is complemented by TrakCel Consulting Services and SI & Digital Transformation Services for implementation and optimization. OCELLOS is available on Salesforce AppExchange and supports autologous, allogeneic, and personalized cancer vaccine therapies across clinical and commercial settings.

Differentiator

Problem solved

Functional benefit

Products and services

  • OCELLOS Modular, Salesforce-powered advanced therapy orchestration platform for cell and gene therapy manufacturers, providing end-to-end visibility from patient enrollment through manufacturing, logistics, and final product delivery with full Chain of Identity and Chain of Custody tracking. Available on Salesforce AppExchange, operational at 350+ sites across 18 countries supporting 20+ therapies.
  • OCELLOS Core OCELLOS Core orchestration product designed for early-stage personalized cell therapy development, supporting both autologous and allogeneic therapies in clinical trial settings.
  • OCELLOS Pay-As-You-Go Rapid, affordable off-the-shelf OCELLOS orchestration with pay-as-you-go pricing for emerging biotechs, providing established best-practice workflows and faster adoption without multi-year enterprise commitments.
  • OCELLOS with SAP CGTO Integration Combined offering integrating OCELLOS with the SAP Cell and Gene Therapy Orchestration (CGTO) module, providing a best-in-class HCP portal backed by SAP for order intake, management, invoicing, real-time updates, exception handling, and improved data governance.
  • SI & Digital Transformation Services System implementation and digital transformation services supporting organizations from clinical to commercial stage, including configuration, validation, data migration, training, commercial launch support, technology architecture, patient services implementation, and quality compliance.
  • TrakCel Consulting Services Expert consultancy covering Chain of Identity and Chain of Custody strategy, data protection compliance, label design and compliance, supply chain risk assessment, and SaaS validation within the pharmaceutical industry.

Quantifiable outcome

  • Up to 50+ hours saved per week by CROs eliminating manual coordination
  • +2 more outcomes

Companies that use TrakCel

Customer profile

Named customers2 records

Segments8 records

Ideal customer profiles5 records

TrakCel technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration17 records

Feature10 records

TrakCel partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core, strategic and minor.

  • LonzacoreTechnology or IntegrationFull integration with Lonza's MODA-ES manufacturing execution system to ensure smooth data flow between scheduling, batch execution and clinical operations. Integration eliminates manual handoffs and provides consistent visibility across manufacturing and trial teams.
  • KörbercoreTechnology or IntegrationIntegration with Körber's PAS-X MES platform enables automated exchange of scheduling and manufacturing data. Partnership provides visibility within manufacturing and fits into TrakCel's orchestration across the wider supply chain.
  • BarTender (Seagull Scientific)coreTechnology or IntegrationCompliant label generation through BarTender software enabling consistent, compliant labels at the click of a button. Labels populate patient-specific information into approved templates regardless of location, language or treatment.
  • BiocaircoreTechnology or IntegrationSpecialty courier integration for automated shipment bookings, collection instructions and real-time shipment updates. Partnership provides full visibility and integration within the complex CGT supply chain.
  • QuickSTATcoreTechnology or IntegrationIntegration with Quick Specialized Healthcare Logistics for automated courier bookings and tracking. Partnership critical for time-sensitive transport of cell therapy materials.
  • MarkencoreTechnology or IntegrationIntegration with Marken's global network of 49 sites including cryogenic service stations and GPS tracking technology for 24/7 monitoring of cell therapy shipments.
  • World CouriercoreTechnology or IntegrationGlobal specialty courier integration for cell and gene therapy logistics providing on-demand access to cell therapy companies as they move through clinical trials to scaled production.
  • CencoracoreTechnology or IntegrationIntegration with patient hub services from Cencora for real-time patient eligibility and benefits verification, live transmission of patient schedule information to case managers, and improved speed-to-therapy.
  • Cardinal HealthcoreTechnology or IntegrationIntegration with Cardinal Health patient hub services providing patient access and reimbursement solutions as part of integrated supply chain for commercial therapies.
  • Be The Match BioTherapiesstrategicStrategic or Co-development PartnerCollaboration to develop custom solutions for individual programs and patient populations. Shared goal of ensuring cell and gene therapies can be developed efficiently and delivered safely to patients.
  • MuleSoftcoreTechnology or IntegrationIntegration platform powering TrakCel's Integration Hub for standardized API connectivity. Enables secure, validated data exchange across all internal and external partners.
  • ZSminorStrategic or Co-development PartnerAnalytics and consulting partnership to deploy expertise helping the industry shift to proactive, predictive analyses that identify and mitigate challenges in cell therapy orchestration.
  • SalesforcecoreTechnology or IntegrationPlatform foundation for OCELLOS - second-generation cellular orchestration platform built on Salesforce Health Cloud and available on Salesforce AppExchange.

Scale indicators11 records

Recent moves7 records

Expansion highlights8 records

TrakCel competitors and assessment

Company assessment

Broad incumbents

  • Salesforce Health Cloud: Healthcare-specific extension of the Salesforce platform that underpins TrakCel's OCELLOS. Comparable as the platform-of-record and a potential competitive incumbent if Salesforce expands native orchestration capabilities within Health Cloud or AppExchange.
  • MasterControl: Provider of quality management, manufacturing execution, and compliance software for life sciences, including CGT manufacturers. Comparable as an incumbent offering overlapping capabilities in QMS, validation, and supply-chain documentation relevant to TrakCel's customers.
  • LabVantage Solutions: Laboratory information management system (LIMS) provider serving pharmaceutical and biotech customers, including cell and gene therapy developers. Comparable as an adjacent incumbent whose informatics footprint could be extended into CGT chain-of-custody and sample tracking use cases.
  • Veeva Systems: Dominant cloud software provider for the life sciences industry across CRM, clinical, regulatory, and quality. Comparable as a broader incumbent in pharma enterprise software with potential to bundle CGT orchestration into its platform, posing a competitive threat from above.
  • SAP Life Sciences: Enterprise ERP vendor that has launched a dedicated Cell and Gene Therapy Orchestration (CGTO) module that TrakCel integrates with. Represents the most direct large-platform competitive threat, leveraging SAP's installed base across pharma to bundle CGT orchestration.
  • Dassault Systèmes BIOVIA: Life sciences R&D, manufacturing, and quality software suite within Dassault Systèmes. Comparable as a broad incumbent whose scientific informatics and lab-to-manufacturing capabilities could be extended into CGT orchestration workflows.

Direct peers

  • Vineti: Pioneer in CGT orchestration software for cell therapy manufacturers and treatment centers, offering patient scheduling, manufacturing coordination, and chain-of-custody tracking. Closest direct competitor to OCELLOS in scope and target buyer, now operating within Autolus Therapeutics' ecosystem.
  • Hypertrust Patient Data Care: Germany-based independent software vendor specializing in chain-of-custody and chain-of-identity orchestration for advanced therapy medicinal products. Direct competitor to TrakCel in CGT supply-chain orchestration, with comparable focus on autologous and allogeneic therapies and treatment-center workflows.

Emerging players

  • Cellares: Emerging cell therapy manufacturing automation company building integrated cell therapy platforms. Relevant as a next-generation CGT manufacturing technology provider whose factory-of-the-future approach intersects with TrakCel's orchestration domain.
  • Ori Biotech: Early-stage company developing automated cell and gene therapy manufacturing platforms with integrated process control. Adjacent emerging player whose manufacturing automation roadmap could overlap with TrakCel's orchestration layer in CGT production environments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

TrakCel social profiles

Digital presence

TrakCel compliance and trust

Trust signal

Compliance1 record

TrakCel financial estimates

Financial estimate

Revenue estimate

Valuation estimate

TrakCel leadership team

Management profile

Number of profiles

Profiles7 records

TrakCel subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

TrakCel funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

TrakCel M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TrakCel

What does TrakCel do?

TrakCel develops and sells OCELLOS, a Salesforce-powered, modular orchestration platform purpose-built for cell and gene therapy manufacturers. The platform digitizes and coordinates the end-to-end advanced therapy value chain — patient enrollment, scheduling, manufacturing, cryogenic logistics, and final product administration — while enforcing Chain of Identity and Chain of Custody. TrakCel also offers SI/Digital Transformation implementation services and TrakCel Consulting Services covering COI/COC strategy, regulatory compliance, label design, and SaaS validation.

Is TrakCel a public or private company?

TrakCel is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was TrakCel founded?

TrakCel was founded in 2012. It employs 51 to 100 people.

Where is TrakCel based?

TrakCel is headquartered in Cardiff, United Kingdom, in the Europe region.

How does TrakCel make money?

Four revenue lines are on record. OCELLOS Platform Subscription is the primary driver. The others are OCELLOS Pay-As-You-Go (PAYG), professional Services and SI and consulting Services.

Who are TrakCel's main competitors?

Broad incumbents on record are Salesforce Health Cloud, MasterControl, LabVantage Solutions, Veeva Systems, SAP Life Sciences and Dassault Systèmes BIOVIA. Direct peers are Vineti and Hypertrust Patient Data Care. Emerging players are Cellares and Ori Biotech.

Does TrakCel have an API?

No public API is recorded for TrakCel.

What industry is TrakCel in?

TrakCel's product category is Cell and Gene Therapy Orchestration Software. Its primary akta.pro industry code is HLAGABAD, Cell Therapy CDMO. Its NAICS code is 5132 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
TrakcelScaling Operational Excellence in Cell and Gene Therapy: The Critical Infrastructure Behind Medical BreakthroughsTrakCel emphasizes the critical need for robust operational infrastructure and specialized software to scale cell and gene therapy delivery from clinical trials to global patient populations. The company highlights that maintaining strict chain of identity and custody, alongside automated workflow optimization, is essential to prevent delays and ensure patient safety as treatments expand across borders.EIN PresswireCellular Therapy Tracking Market to Reach $4.71 Billion by 2029 with 12.9% CAGRThe cellular therapy tracking market is projected to grow from $2.56 billion in 2024 to $4.71 billion by 2029, representing a 12.9% compound annual growth rate, driven by increased adoption of personalized medicine, growing cell and gene therapy pipelines, and rising clinical trial activity. The report identifies North America as the leading regional market, with key growth trends including the integration of AI and machine learning, digital healthcare platforms, and chain of identity management solutions for patient safety and regulatory compliance. UK-based TrakCel Limited launched its OCELLOS Core platform in May 2023 to address traceability needs in autologous cell therapy trials.openPR.comCell & Gene Therapy Supply Chain Software Market Key Players Analysis - Biocair, LabVantage Solutions, Lonza, TraceLink, TrakCel, Veeva Systems.InsightAce Analytic released a market assessment report on the global cell and gene therapy supply chain software market, projecting it to exceed USD 668.4 million by 2031 at a 13.9% CAGR. The report highlights drivers like personalized medicine demand and challenges such as high software costs and regulatory complexity. Recent developments include Veeva Systems' partnership with SK Biopharmaceuticals and Cryoport's acquisition of Tec4med.Drug Development and DeliveryCELL & GENE THERAPY - It’s Time to Build Infrastructure to Handle the Coming SurgeCardinal Health is building advanced infrastructure to support the development, manufacturing, and distribution of cell and gene therapies amid a projected surge in demand. The company has partnered with TrakCel to provide integrated software solutions for managing the precise logistics and tracking of these complex treatments. This initiative aims to address current barriers related to patient access, cold-chain storage, and data collection as the market expands significantly.BusinessCloudMedTech 50 firm TrakCel expands partner ecosystemTrakCel is expanding its OCELLOS partner ecosystem, bringing the total number of integrated partners to 20 by the end of 2024. The Cardiff-based cellular orchestration provider supports over 25 CGTs, and the expansion aims to give developers more options for manufacturing complex cell and gene therapies.PharmiWeb.comTrakCel to expand largest commercial CGT integrated partner network to meet industry’s growing needsTrakCel will expand its OCELLOS cellular orchestration partner network by over 40% in 2024, bringing the total to 20 integrated partners. The expansion aims to support CGT developers with logistics, manufacturing, and labelling services. The company expects continued growth to meet industry needs.biopharma-reporter.comTrakCel launches consultancy services to share industry expertiseTrakCel launched consultancy services to help therapy developers navigate clinical environments, covering identity strategy, data protection, label design, supply chain risk, and SaaS. The services are managed by co-founder Matthew Lakelin, who will lead a team of consultants. TrakCel currently supports over 25 CGTs at every step of clinical development.Labiotech.euBeyond Biotech podcast 32: Cancer Research Horizons, Enterome, OncoHost, TrakCel, TurbineA podcast episode features interviews with executives from OncoHost, TrakCel, Enterome, and Turbine, covering cancer research topics. OncoHost launched its PROphet NSCLC test in the U.S., which predicts treatment benefit from immunotherapy. Enterome's Phase 2 trials for EO2401 showed efficacy in glioblastoma and adrenal malignancies.BioSpaceAmerisourceBergen and TrakCel Launch Integrated Platform to Support Cell and Gene TherapiesAmerisourceBergen and TrakCel unveiled an integrated platform combining OCELLOS and Fusion to accelerate patient access to cell and gene therapies. The platform improves connectivity between providers and hub patient services, expediting enrollment and support. It aims to streamline the path to care and enhance supply chain visibility.